Going forward, the software segment is expected to be the fastest growing segment in the clinical decision support systems market segmented by component, at a CAGR of 14.77% during 2024-2029.

GenXys' clinical decision support software suite is in use by major insurance providers, health systems, pharmacies and their pharmacogenetic labs across North America.

MEETING THE CHALLENGE The implementation followed a carefully structured approach. Phase One began with a soft launch to assess the system's integration with physician workflow. The system was ...

In recommending solutions, NASEM observed that, “A number of studies have shown that clinical decision support systems can improve the rates of certain desirable clinician behaviors such as ...

Together, the proposals should improve transparency and promote trustworthiness of clinical decision support tools by enabling users, like providers, to better scrutinize them, the ONC said.

The global clinical decision support systems market is expected to reach $5.75b by 2029 from 2024 at a compound annual growth rate of 12.86%, according to a Research and Markets report.

In this study, we aimed to develop and validate a decision support system (DSS) to define the optimal timing of HSCT in patients with MDS on the basis of clinical and genomic information as provided ...

The global clinical decision support systems market is set for robust growth, expanding from $3.14 billion in 2024 to $10.74 billion by 2034, fueled by a demand for AI-driven solutions and increasing ...